For specialists

Results of a multicenter study of the effectiveness of Helicobacter pylori eradication, carried out in accordance with the recommendations of the Maastricht Consensus V
Published in the journal «Modern gastroenterology» № 1 (105)’2019
Selecting the Optimal Proton Pump Inhibitor for Patients with Coronary Artery Disease Who Require Dual Antiplatelet Therapy
Published in the journal «Arterial Hypertension» № 1 (57)’2018
Drug prevention and treatment of gastropathies associated with the use of non-steroidal anti-inflammatory drugs
Published in the journal «Modern gastroenterology» № 3 (89)’2016
Ulsepan (pantoprazole) as an effective means of preventing erosive and ulcerative lesions of the gastroduodenal zone in patients during surgical interventions on the organs of the gastrointestinal tract
Published in the journal «Emergency Medicine» № 1 (96)’2019
Modern approaches to the treatment and prevention of gastrointestinal bleeding associated with NSAID gastropathy and stress ulcers
Published in the journal «District Doctor» № 2 (72)’2019
Experience of using pantoprazole (Ulsepan) and a combined synbiotic (Opefera) in the complex therapy of children with gastroesophageal reflux disease and gastroduodenitis
Published in the journal «Medicine of Ukraine» № 9-10 (215-216)’2017
Experience of using pantoprazole in the complex therapy of diseases of the digestive tract of different age groups
Published in the journal «Medicine of Ukraine» № 3 (209)’2017
Diaphragmatic hernia: mechanisms of formation, clinic, treatment tactics
Published in the journal «Bulletin of the club of pancreatologists» аugust’2019
Innovative approaches in the combined treatment of onychia and dermatomycosis in patients of different age groups. New experience in the clinical use of drugs in the practice of a dermatovenerologist
Published in the journal «Ukrainian Journal of Dermatology, Venereology, Cosmetology» № 3 (66)’2017
Onychomycosis: epidemiology, etiopathogenesis, diagnosis, treatment
Published in the journal «Dermatology and Venereology» № 2 (80)’2018

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design